United States Covid-19 vaccine maker Moderna and Zuellig Pharma Corp. jointly requested the Philippine Food and Drug Administration for an emergency use authorization (EUA) for mRNA-1273.
In this file photo taken on May 18, 2020, a man stands outside Moderna headquarters in Cambridge, Massachusetts. US biotech firm Moderna on November 16, 2020 announced its experimental vaccine against Covid-19 was 94.5 percent effective, marking a second major breakthrough in the vaccine hunt. / AFP / Joseph Prezioso